{"id":3903,"date":"2025-01-08T18:03:59","date_gmt":"2025-01-08T12:33:59","guid":{"rendered":"https:\/\/indianlawsociety.com\/?p=3903"},"modified":"2025-01-13T18:38:08","modified_gmt":"2025-01-13T13:08:08","slug":"revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates","status":"publish","type":"post","link":"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/","title":{"rendered":"Revisions to the Strengthening of Pharmaceuticals Industry (SPI) Scheme: Key Updates"},"content":{"rendered":"<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><span class=\"ng-star-inserted\">The Indian government has made some key amendments to the guidelines of the &#8220;Strengthening of Pharmaceuticals Industry&#8221; (SPI) scheme. This corrigendum highlights changes to specific clauses related to timelines for technological upgradation and eligibility for cluster formation. This article will provide a brief overview of these changes.<\/span><\/p>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Purpose of the Corrigendum:<\/span><\/strong><\/p>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><span class=\"ng-star-inserted\">The Department of Pharmaceuticals has issued this corrigendum to the SPI scheme based on industry feedback and representations received after the initial guidelines were published on March 11, 2022. The changes aim to make the scheme more effective and accommodating for stakeholders.<\/span><\/p>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Key Modifications:<\/span><\/strong><\/p>\n<ul class=\"ng-star-inserted\" style=\"text-align: justify;\">\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Extended Technological Upgradation Timeline:<\/span><\/strong><span class=\"ng-star-inserted\">\u00a0The timeline for technological upgradation under the scheme has been extended from 18 to 30 months from the date of the first loan disbursement for both the general and MSME categories.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Pharma MSMEs:<\/span><\/strong><span class=\"ng-star-inserted\">\u00a0The deadline for Pharma MSMEs to achieve technological upgradation and be eligible for interest subvention has been changed from 18 to 30 months from the date of first loan disbursal. Failure to do so will convert the loan into a regular loan.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Clarification on Cluster Formation:<\/span><\/strong><span class=\"ng-star-inserted\">\u00a0The corrigendum clarifies that existing clusters registered under the Companies Act are considered for processing. A separate cluster formation is not needed in such instances.<\/span><\/p>\n<\/li>\n<\/ul>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Revised Clauses:<\/span><\/strong><br class=\"ng-star-inserted\" \/><span class=\"ng-star-inserted\">The document specifies the following amendments:<\/span><\/p>\n<ul class=\"ng-star-inserted\" style=\"text-align: justify;\">\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Clause 8.2.5 (PT-UAS XVII):<\/span><\/strong><span class=\"ng-star-inserted\">\u00a0The technological upgradation timeline is revised to 30 months from the first loan disbursement.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Clause 8.2.8:<\/span><\/strong><span class=\"ng-star-inserted\">\u00a0Pharma MSMEs now have 30 months to achieve technological upgrades to maintain interest subvention eligibility, instead of 18 months<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Clause 8.1.2 (API-CF):<\/span><\/strong><span class=\"ng-star-inserted\">\u00a0Existing registered clusters do not need to form new separate entities.<\/span><\/p>\n<\/li>\n<\/ul>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Impact of the Changes:<\/span><\/strong><\/p>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><span class=\"ng-star-inserted\">These changes provide several benefits to eligible entities:<\/span><\/p>\n<ul class=\"ng-star-inserted\" style=\"text-align: justify;\">\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Increased time flexibility for undertaking technological upgradation.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">More realistic deadlines for MSMEs to meet upgrade requirements.<\/span><\/p>\n<\/li>\n<li class=\"ng-star-inserted\">\n<p class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Reduced burden and simplified processes for existing pharmaceutical clusters.<\/span><\/p>\n<\/li>\n<\/ul>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">No Change in Other Provisions:<\/span><\/strong><br class=\"ng-star-inserted\" \/><span class=\"ng-star-inserted\">All other provisions as contained in the original guidelines published on March 11, 2022 remain unchanged. These include eligibility criteria, activities covered, and funding mechanisms.<\/span><\/p>\n<p class=\"ng-star-inserted\" style=\"text-align: justify;\"><strong class=\"ng-star-inserted\"><span class=\"ng-star-inserted\">Conclusion:<\/span><\/strong><br class=\"ng-star-inserted\" \/><span class=\"ng-star-inserted\">The corrigendum to the SPI scheme underscores the government&#8217;s commitment to addressing the needs of the pharmaceutical industry by providing clear pathways for compliance and improved access to the scheme\u2019s benefits. These modifications allow for better planning, smoother implementation and wider participation in the scheme.<\/span><\/p>\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/Scheme-for-Strengthening-of-Pharmaceuticals-Industry-SPI.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of Scheme for Strengthening of Pharmaceuticals Industry (SPI).\"><\/object><a id=\"wp-block-file--media-0ae2d9be-8b73-4ea2-9435-1f80e9259f9f\" href=\"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/Scheme-for-Strengthening-of-Pharmaceuticals-Industry-SPI.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Scheme for Strengthening of Pharmaceuticals Industry (SPI)<\/a><a href=\"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/Scheme-for-Strengthening-of-Pharmaceuticals-Industry-SPI.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-0ae2d9be-8b73-4ea2-9435-1f80e9259f9f\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"The Indian government has made some key amendments to the guidelines of the &#8220;Strengthening of Pharmaceuticals Industry&#8221; (SPI) scheme. This corrigendum highlights changes to specific clauses related to timelines for technological upgradation and eligibility for cluster formation.","protected":false},"author":1,"featured_media":6057,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"footnotes":""},"categories":[358,25,49],"tags":[646,648,649,644,647,645],"class_list":{"0":"post-3903","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-chemicals-and-fertilizers","8":"category-law-library","9":"category-schemes-and-yojanas","10":"tag-indian-pharma","11":"tag-msme","12":"tag-pharmaceutical-loan","13":"tag-pharmaceutical-upgradation","14":"tag-spi-scheme","15":"tag-strengthening-of-pharmaceuticals-industry","16":"cs-entry","17":"cs-video-wrap"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Revisions to the Strengthening of Pharmaceuticals Industry (SPI) Scheme: Key Updates<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revisions to the Strengthening of Pharmaceuticals Industry (SPI) Scheme: Key Updates\" \/>\n<meta property=\"og:description\" content=\"The Indian government has made some key amendments to the guidelines of the &quot;Strengthening of Pharmaceuticals Industry&quot; (SPI) scheme. This corrigendum highlights changes to specific clauses related to timelines for technological upgradation and eligibility for cluster formation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/\" \/>\n<meta property=\"og:site_name\" content=\"Insights by Karma AI\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-08T12:33:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-13T13:08:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/steptodown.com184720.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1224\" \/>\n\t<meta property=\"og:image:height\" content=\"816\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Karma AI\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Karma AI\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\\\/\"},\"author\":{\"name\":\"Karma AI\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#\\\/schema\\\/person\\\/cfb78f37dfe74f0397dc673286495f01\"},\"headline\":\"Revisions to the Strengthening of Pharmaceuticals Industry (SPI) Scheme: Key Updates\",\"datePublished\":\"2025-01-08T12:33:59+00:00\",\"dateModified\":\"2025-01-13T13:08:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\\\/\"},\"wordCount\":384,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/karma.law\\\/insights\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/steptodown.com184720.jpg\",\"keywords\":[\"Indian Pharma\",\"MSME\",\"Pharmaceutical Loan\",\"Pharmaceutical Upgradation\",\"SPI Scheme\",\"Strengthening of Pharmaceuticals Industry\"],\"articleSection\":[\"Chemicals &amp; Fertilizers\",\"Law Library\",\"Schemes &amp; Yojanas\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\\\/\",\"url\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\\\/\",\"name\":\"Revisions to the Strengthening of Pharmaceuticals Industry (SPI) Scheme: Key Updates\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/karma.law\\\/insights\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/steptodown.com184720.jpg\",\"datePublished\":\"2025-01-08T12:33:59+00:00\",\"dateModified\":\"2025-01-13T13:08:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\\\/#primaryimage\",\"url\":\"https:\\\/\\\/karma.law\\\/insights\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/steptodown.com184720.jpg\",\"contentUrl\":\"https:\\\/\\\/karma.law\\\/insights\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/steptodown.com184720.jpg\",\"width\":1224,\"height\":816},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/law-library\\\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/karma.law\\\/insights\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revisions to the Strengthening of Pharmaceuticals Industry (SPI) Scheme: Key Updates\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#website\",\"url\":\"https:\\\/\\\/karma.law\\\/insights\\\/\",\"name\":\"Insights by Karma AI\",\"description\":\"Law Simplified\",\"publisher\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#organization\"},\"alternateName\":\"Insights by Karma AI\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/karma.law\\\/insights\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#organization\",\"name\":\"Karma AI - Think Legal\",\"url\":\"https:\\\/\\\/karma.law\\\/insights\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/karma.law\\\/insights\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/cropped-icon-1.png\",\"contentUrl\":\"https:\\\/\\\/karma.law\\\/insights\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/cropped-icon-1.png\",\"width\":512,\"height\":512,\"caption\":\"Karma AI - Think Legal\"},\"image\":{\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/karma.law\\\/insights\\\/#\\\/schema\\\/person\\\/cfb78f37dfe74f0397dc673286495f01\",\"name\":\"Karma AI\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3dc55b7c8c787d0bfb152056f4cea70a8f439b177f173ba6a8e712e0688bb021?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3dc55b7c8c787d0bfb152056f4cea70a8f439b177f173ba6a8e712e0688bb021?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3dc55b7c8c787d0bfb152056f4cea70a8f439b177f173ba6a8e712e0688bb021?s=96&d=mm&r=g\",\"caption\":\"Karma AI\"},\"sameAs\":[\"https:\\\/\\\/karma.law\\\/insights\"],\"url\":\"https:\\\/\\\/karma.law\\\/insights\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Revisions to the Strengthening of Pharmaceuticals Industry (SPI) Scheme: Key Updates","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/","og_locale":"en_US","og_type":"article","og_title":"Revisions to the Strengthening of Pharmaceuticals Industry (SPI) Scheme: Key Updates","og_description":"The Indian government has made some key amendments to the guidelines of the \"Strengthening of Pharmaceuticals Industry\" (SPI) scheme. This corrigendum highlights changes to specific clauses related to timelines for technological upgradation and eligibility for cluster formation.","og_url":"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/","og_site_name":"Insights by Karma AI","article_published_time":"2025-01-08T12:33:59+00:00","article_modified_time":"2025-01-13T13:08:08+00:00","og_image":[{"width":1224,"height":816,"url":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/steptodown.com184720.jpg","type":"image\/jpeg"}],"author":"Karma AI","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Karma AI","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/#article","isPartOf":{"@id":"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/"},"author":{"name":"Karma AI","@id":"https:\/\/karma.law\/insights\/#\/schema\/person\/cfb78f37dfe74f0397dc673286495f01"},"headline":"Revisions to the Strengthening of Pharmaceuticals Industry (SPI) Scheme: Key Updates","datePublished":"2025-01-08T12:33:59+00:00","dateModified":"2025-01-13T13:08:08+00:00","mainEntityOfPage":{"@id":"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/"},"wordCount":384,"commentCount":0,"publisher":{"@id":"https:\/\/karma.law\/insights\/#organization"},"image":{"@id":"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/#primaryimage"},"thumbnailUrl":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/steptodown.com184720.jpg","keywords":["Indian Pharma","MSME","Pharmaceutical Loan","Pharmaceutical Upgradation","SPI Scheme","Strengthening of Pharmaceuticals Industry"],"articleSection":["Chemicals &amp; Fertilizers","Law Library","Schemes &amp; Yojanas"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/","url":"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/","name":"Revisions to the Strengthening of Pharmaceuticals Industry (SPI) Scheme: Key Updates","isPartOf":{"@id":"https:\/\/karma.law\/insights\/#website"},"primaryImageOfPage":{"@id":"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/#primaryimage"},"image":{"@id":"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/#primaryimage"},"thumbnailUrl":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/steptodown.com184720.jpg","datePublished":"2025-01-08T12:33:59+00:00","dateModified":"2025-01-13T13:08:08+00:00","breadcrumb":{"@id":"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/#primaryimage","url":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/steptodown.com184720.jpg","contentUrl":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/steptodown.com184720.jpg","width":1224,"height":816},{"@type":"BreadcrumbList","@id":"https:\/\/karma.law\/insights\/law-library\/revisions-to-the-strengthening-of-pharmaceuticals-industry-spi-scheme-key-updates\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/karma.law\/insights\/"},{"@type":"ListItem","position":2,"name":"Revisions to the Strengthening of Pharmaceuticals Industry (SPI) Scheme: Key Updates"}]},{"@type":"WebSite","@id":"https:\/\/karma.law\/insights\/#website","url":"https:\/\/karma.law\/insights\/","name":"Insights by Karma AI","description":"Law Simplified","publisher":{"@id":"https:\/\/karma.law\/insights\/#organization"},"alternateName":"Insights by Karma AI","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/karma.law\/insights\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/karma.law\/insights\/#organization","name":"Karma AI - Think Legal","url":"https:\/\/karma.law\/insights\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/karma.law\/insights\/#\/schema\/logo\/image\/","url":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/cropped-icon-1.png","contentUrl":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/cropped-icon-1.png","width":512,"height":512,"caption":"Karma AI - Think Legal"},"image":{"@id":"https:\/\/karma.law\/insights\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/karma.law\/insights\/#\/schema\/person\/cfb78f37dfe74f0397dc673286495f01","name":"Karma AI","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/3dc55b7c8c787d0bfb152056f4cea70a8f439b177f173ba6a8e712e0688bb021?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3dc55b7c8c787d0bfb152056f4cea70a8f439b177f173ba6a8e712e0688bb021?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3dc55b7c8c787d0bfb152056f4cea70a8f439b177f173ba6a8e712e0688bb021?s=96&d=mm&r=g","caption":"Karma AI"},"sameAs":["https:\/\/karma.law\/insights"],"url":"https:\/\/karma.law\/insights\/author\/admin\/"}]}},"jetpack_featured_media_url":"https:\/\/karma.law\/insights\/wp-content\/uploads\/2025\/01\/steptodown.com184720.jpg","_links":{"self":[{"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/posts\/3903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/comments?post=3903"}],"version-history":[{"count":1,"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/posts\/3903\/revisions"}],"predecessor-version":[{"id":3910,"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/posts\/3903\/revisions\/3910"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/media\/6057"}],"wp:attachment":[{"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/media?parent=3903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/categories?post=3903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/karma.law\/insights\/wp-json\/wp\/v2\/tags?post=3903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}